Diabetes Clinical Trials in San Francisco

Showing 21-40 of 255 trials

Reducing Treatment Risk in Older Adults With Diabetes

NCT04585191

This study will evaluate the impact of academic detailing (evidence-based provider education) with or without patient pre-visit preparation (elicitation of values and preferences) on safe insulin de-prescribing among older patients with type 2 diabetes at risk for hypoglycemia. The hypothesis is that patients who are well-prepared for their primary care visit will engage in more informed discussions with their providers regarding re-evaluation of current treatment regimens. In clinically appropriate cases, these more effective discussions will result in safe de-prescribing and fewer future episodes of hypoglycemia.

Type 2 Diabetes Treated With InsulinHypoglycemiaPrimary Health Care+1 more

Kaiser Permanente450 participantsStarted Nov 2020

San Francisco, California, United States • San Leandro, California, United States • Union City, California, United States +1 more locations

COMPLETEDNA< 1 mile

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

NCT05714059

The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.

Type 1 Diabetes

Medtronic Diabetes250 participantsStarted Feb 2023

Little Rock, Arkansas, United States • Palo Alto, California, United States • San Francisco, California, United States +20 more locations

Reducing Treatment Risk in Older Adults With Diabetes

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Diabetes Trials in Other Cities

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Addressing Diabetes by Elevating Access to Nutrition

Omnipod 5 System Compared to Pump Therapy

The Pediatric Artificial Pancreas Automated Initialization Trial

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

Regional Fat Depots and Insulin Resistance

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

MIRACLE of LIFE Study

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Other Conditions in San Francisco